Endo And Allergan Reach Settlements That Will Allow Them To Bow Out Of Landmark Opioid Trial
The trial, which is scheduled to begin Oct. 21 in Ohio, is largely viewed as a bellwether of how hard drugmakers will be hit over claims that they played a role in the opioid epidemic. Both Endo and Allergan are small players, and much of the spotlight will be on Purdue Pharma and Johnson & Johnson.
Reuters:
Drugmakers Endo, Allergan Agree To $15 Million In Settlements In Major Opioid Case
Endo International Plc and Allergan Plc have agreed to pay $15 million to avoid going to trial in October in a landmark case by two Ohio counties accusing various drug manufacturers and distributors of fueling the U.S. opioid epidemic. The tentative deals disclosed on Tuesday came ahead of the first trial to result from 2,000 lawsuits pending in federal court in Cleveland largely by local governments seeking to hold drug companies responsible for the deadly epidemic. (Raymond, 8/20)
Stat:
Endo Agrees To Pay $10 Million To Settle Landmark Opioid Case Brought By Ohio Counties
The trial, which is scheduled to begin in Oct. 21, will be the first to test arguments made by numerous cities, counties, Native American tribes, and still others that several drug makers and distributors fomented the crisis. Some 2,000 lawsuits have been combined in a massive litigation in a federal court in Cleveland, where a judge has been urging a settlement. The local governments and other entities are seeking compensation to cover the costs of treating addiction and abuse. (Silverman, 8/20)
Bloomberg:
Endo Escapes First Of Opioid Test Trials In $11 Million Pact - Bloomberg
Endo officials said the Ohio settlement didn’t reflect what it expects to pay to resolve the other opioid suits. “The cash portion of the settlement approximates the estimated cost to Endo of proceeding through trial,” Matthew Maletta, Endo’s executive vice president and chief legal officer, said in an emailed statement. (Feeley and Griffin, 8/20)
Cleveland Plain Dealer:
Opioid Makers Agree To $15 Million In Settlements With Cuyahoga, Summit Counties In Advance Of October Trial
The companies are on the smaller end of those facing similar suits. OxyContin maker Purdue Pharma, generic drug manufacturer Mallinckrodt and Ohio-based distributor Cardinal Health are also defendants. The settlements are not final. Endo, which manufactures Opana, has agreed to pay $10 million and provide $1 million of two of its drugs free of charge, according to a news release the company put out Tuesday. Frank Gallucci, an attorney representing Cuyahoga County, confirmed the tentative terms. (Heisig, 8/20)
